These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 19579886)

  • 1. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update.
    Gontero P; Birtle A; Capoun O; Compérat E; Dominguez-Escrig JL; Liedberg F; Mariappan P; Masson-Lecomte A; Mostafid HA; Pradere B; Rai BP; van Rhijn BWG; Seisen T; Shariat SF; Soria F; Soukup V; Wood R; Xylinas EN
    Eur Urol; 2024 Aug; ():. PubMed ID: 39155194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models.
    Guerrero-Ramos F; Subiela JD; Rodríguez-Faba Ó; Aumatell J; Manfredi C; Bozzini G; Romero-Otero J; Couñago F
    Bladder Cancer; 2022; 8(4):339-357. PubMed ID: 38994181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.
    de Jong JJ; Lotan Y; Boormans JL
    Eur Urol; 2024 Aug; ():. PubMed ID: 39129108
    [No Abstract]   [Full Text] [Related]  

  • 4. The diagnostic and prognostic value of nuclear matrix protein 22 in bladder cancer.
    Tang X; Cao Y; Liu J; Wang S; Yang Y; Du P
    Transl Cancer Res; 2020 Nov; 9(11):7174-7182. PubMed ID: 35117321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells' Pluripotency in Bladder Cancer.
    Rubio C; Avendaño-Ortiz J; Ruiz-Palomares R; Karaivanova V; Alberquilla O; Sánchez-Domínguez R; Casalvilla-Dueñas JC; Montalbán-Hernández K; Lodewijk I; Rodríguez-Izquierdo M; Munera-Maravilla E; Nunes SP; Suárez-Cabrera C; Pérez-Crespo M; Martínez VG; Morales L; Pérez-Escavy M; Alonso-Sánchez M; Lozano-Rodríguez R; Cueto FJ; Aguirre LA; Guerrero-Ramos F; Paramio JM; López-Collazo E; Dueñas M
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaching the optimal transurethral resection of a bladder tumor.
    Jurewicz M; Soloway MS
    Turk J Urol; 2014 Jun; 40(2):73-7. PubMed ID: 26328154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
    Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
    Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer.
    Chen M; Hildebrandt MA; Clague J; Kamat AM; Picornell A; Chang J; Zhang X; Izzo J; Yang H; Lin J; Gu J; Chanock S; Kogevinas M; Rothman N; Silverman DT; Garcia-Closas M; Grossman HB; Dinney CP; Malats N; Wu X
    Cancer Prev Res (Phila); 2010 Oct; 3(10):1235-45. PubMed ID: 20858759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.
    Babjuk M; Oosterlinck W; Sylvester R; Kaasinen E; Böhle A; Palou-Redorta J; Rouprêt M;
    Eur Urol; 2011 Jun; 59(6):997-1008. PubMed ID: 21458150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).
    Babjuk M; Burger M; Capoun O; Cohen D; Compérat EM; Dominguez Escrig JL; Gontero P; Liedberg F; Masson-Lecomte A; Mostafid AH; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Seisen T; Soukup V; Sylvester RJ
    Eur Urol; 2022 Jan; 81(1):75-94. PubMed ID: 34511303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [EAU guidelines on non-muscle-carcinoma of the bladder].
    Babjuk M; Oosterlinck W; Sylvester R; Kaasinen E; Böhle A; Palou-Redorta J;
    Actas Urol Esp; 2009 Apr; 33(4):361-71. PubMed ID: 19579886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
    Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
    Babjuk M; Burger M; Zigeuner R; Shariat SF; van Rhijn BW; Compérat E; Sylvester RJ; Kaasinen E; Böhle A; Palou Redorta J; Rouprêt M;
    Eur Urol; 2013 Oct; 64(4):639-53. PubMed ID: 23827737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder.
    Babjuk M; Oosterlinck W; Sylvester R; Kaasinen E; Böhle A; Palou-Redorta J;
    Eur Urol; 2008 Aug; 54(2):303-14. PubMed ID: 18468779
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.